Results 181 to 190 of about 60,739 (253)

Intraluminal Vesicles as Transfection Intermediaries. [PDF]

Pharmaceutics
Mahmoud NAM, Abdelrahman HKS, Feron BKL, Pintilie A, Fivaz M, Miest-Bray JJ, Gomez T, Youens N, Tripathi V, Richardson SCW.   +9 more
europepmc   +1 more source

The Effect of a Dominant Inhibitory p53 Protein on Stress Responses Induced by Toxic and Non-Toxic Concentrations of Anisomycin in PC12 Cells. [PDF]

Biology (Basel)
Schipp R, Varga J, Bátor J, Vecsernyés M, Árvai Z, Kele-Morvai P, Szeberényi J, Pap M.   +7 more
europepmc   +1 more source

A Map of the Arenavirus Nucleoprotein-Host Protein Interactome Reveals that Junín Virus Selectively Impairs the Antiviral Activity of Double-Stranded RNA-Activated Protein Kinase (PKR)

Journal of Virology, 2017
B. King, Dylan Hershkowitz, Philip L. Eisenhauer, Marion E Weir, Christopher M Ziegler, Joanne Russo, E. Bruce, B. Ballif, J. Botten   +8 more
semanticscholar   +1 more source

Human alphacoronavirus replication and innate immune induction in airway culture systems. [PDF]

mBio
Fausto A, Otter CJ, Torres L, Blomqvist EK, Bracci N, Renner DM, Tan LH, Mooring D, Ebert N, Trüeb B, Thiel V, Cohen NA, Burke JM, Weiss SR.   +13 more
europepmc   +1 more source

PACT suppresses PKR activation through dsRNA binding and dimerization, and is a therapeutic target for triple-negative breast cancer. [PDF]

RNA
Young AA, Juhler IG, Pierce JR, Bohlin HE, Harper HA, Onishile DS, Chua RN, Liu ME, Gardner EN, Elzey BD, Cottrell KA.   +10 more
europepmc   +1 more source

Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.

Biochimica et Biophysica Acta - Molecular Basis of Disease, 2018
Hsiao-yun Chen, Liang-Ting Lin, Mong-Lien Wang, Kun-Ling Tsai, Pin‐I Huang, Yi-ping Yang, Yi-Yen Lee, Yi-Wei Chen, W. Lo, Y. Lan, S. Chiou, Chien-Min Lin, Hsin-I. Ma, Ming-Teh Chen   +13 more
semanticscholar   +1 more source

Identification of ADAR1i-124: The first effective A-to-I RNA editing inhibitor with promising cancer therapeutic potential. [PDF]

iScience
Minakuchi M, Zhang H, Cassel J, Shiromoto Y, Villanueva J, Skordalakes E, Salvino JM, Li Q, Nishikura K.   +8 more
europepmc   +1 more source

Circular nucleic acids at the host-virus interface: from immune modulation to therapeutic innovation. [PDF]

Front Immunol
Lou J, Liu J, Zhang D, Hao Y.
europepmc   +1 more source

Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR

Journal of Virology, 2017
Kristina L Schierhorn, Fabian Jolmes, Julia Bespalowa, Sandra Saenger, C. Peteranderl, Julia Dzieciolowski, M. Mielke, M. Budt, S. Pleschka, A. Herrmann, S. Herold, T. Wolff   +11 more
semanticscholar   +1 more source

The role of ADAR1 in human pathophysiology. [PDF]

Front Cell Dev Biol
Li J, Xiao Y, Li X, Dai Y.
europepmc   +1 more source